Shawn Singh
Chief Executive Officer chez VISTAGEN THERAPEUTICS, INC.
Fortune : 139 962 $ au 31/03/2024
Profil
Shawn K.
Singh is currently the Chief Executive Officer & Director at VistaGen Therapeutics, Inc. He is also a Director at Clear Sky Enhanced Inflation Carbon Offshore Ltd., a Member of The State Bar of California, and the Chief Operating Officer & General Counsel at Cato Holding Co. Previously, Mr. Singh held positions such as Chief Executive Officer & Director at Excaliber Enterprises Ltd., Chief Executive Officer at VistaGen Therapeutics, Inc., Chief Executive Officer at VistaGen, Inc., Chairman at Sontra Medical Corp., Chairman at Durham Pharmaceuticals, Chairman at Echo Therapeutics, Inc., Director at Hemodynamic Therapeutics, Inc., Director at Echo Therapeutics, Inc., Managing Director at Start-up Law, Chief Business Officer at SciClone Pharmaceuticals LLC, Corporate Finance Associate at Morrison & Foerster LLP, Chief Business Officer & General Counsel at Cato Research LLC, President at Artemis Neuroscience, Inc., Managing Principal at Cato BioVentures, and Principal at Celerity Fund, Inc.Mr. Singh obtained his undergraduate degree from the University of California, Berkeley and his graduate degree from The University of Maryland Francis King Carey School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/12/2023 | 26 508 ( 0,10% ) | 139 962 $ | 31/03/2024 |
Postes actifs de Shawn Singh
| Sociétés | Poste | Début |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Chief Executive Officer | 01/08/2009 |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
| Cato Holding Co. | Chief Operating Officer | - |
| Clear Sky Enhanced Inflation Carbon Offshore Ltd. | Director/Board Member | - |
Anciens postes connus de Shawn Singh
| Sociétés | Poste | Fin |
|---|---|---|
| ECHO THERAPEUTICS, INC. | President | 14/12/2011 |
Excaliber Enterprises Ltd.
 Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | President | 10/06/2011 |
VistaGen Therapeutics, Inc. /Old/
 VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | President | 10/06/2011 |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | General Counsel | 01/08/2009 |
Hemodynamic Therapeutics, Inc.
 Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Director/Board Member | 01/08/2009 |
Formation de Shawn Singh
| University of California, Berkeley | Undergraduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 19 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Sontra Medical Corp.
 Sontra Medical Corp. Medical SpecialtiesHealth Technology Sontra Medical Corporation engages in the development of transdermal diagnostic and drug delivery products based on its SonoPrep ultrasonic skin permeation technology. SonoPrep is a noninvasive ultrasonic skin permeation technology for medical and therapeutic applications, including transdermal diagnostics and the delivery of drugs through the skin | Health Technology |
Excaliber Enterprises Ltd.
Excaliber Enterprises Ltd. Internet Software/ServicesTechnology Services Excaliber Enterprises Ltd. is a development stage company. It is engaged in the business of selling specialty gift baskets to health care professionals, organizations and patients, and real estate agents and firms. The company was founded on October 6, 2005 and is headquartered in Rathdrum, ID. | Technology Services |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | Health Technology |
Artemis Neuroscience, Inc.
 Artemis Neuroscience, Inc. BiotechnologyHealth Technology Part of VistaGen Therapeutics, Inc., Artemis Neuroscience, Inc. develops biopharmaceutical products. Artemis Neuroscience was acquired by VistaGen Therapeutics, Inc. on November 19, 2003. | Health Technology |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Cato BioVentures
 Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Finance |
| Cato Holding Co. | |
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Health Technology |
Celerity Fund, Inc.
 Celerity Fund, Inc. Investment ManagersFinance Founded by James F. Brown, James Burness, Didier Perez and Shawn Singh, Celerity Fund, Inc. is a private equity firm. Headquartered in San Francisco. They manage the Celerity Fund LP. | Finance |
| Durham Pharmaceuticals | |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
| Start-up Law | |
| VistaGen, Inc. | |
Armour Therapeutics, Inc.
 Armour Therapeutics, Inc. Medical/Nursing ServicesHealth Services Armour Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development of a new class of anti-hormone therapeutics for the treatment of reproductive tissue-based cancers. The company was founded by Josh Silvertown in 2009 and is headquartered in Toronto, Canada. | Health Services |
| Clear Sky Enhanced Inflation Carbon Offshore Ltd. | |
| Echo Therapeutics, Inc. /Old/ | Health Technology |
